DUGiDocsStudy of the use of medicines for the treatment of attention deficit and hyperactivity disorder in Catalonia
dc.contributor
dc.contributor.author
dc.contributor.other
dc.date.accessioned
2017-07-04T07:55:56Z
dc.date.available
2017-07-04T07:55:56Z
dc.date.issued
2017-02
dc.identifier.uri
dc.description.abstract
Hypothesis: This is a descriptive study for which no hypothesis has been formulated.
Objectives:
1- To determine the prevalence of consumption of drugs authorized for the treatment of ADHD in Catalonia.
2- To know sociodemographic and clinical characteristics of patients receiving treatment with drugs authorized for ADHD in Catalonia.
3- To evaluate the follow-up degree of the use recommendations these drugs to the recommendations of the technical file.
4- To study the drug consumption evolution for the treatment of ADHD in the period comprised between 2010 and 2015, in Catalonia and Girona.
Material and Methods:
Two studies of drug use were carried out. The first one addressed the objectives 1-3 and the second one the number 4.
Design:
A descriptive cross-sectional study was carried out.
Study population:
Patients receiving treatment with methylphenidate (MPH), lisdexamphetamine (LDX) or atomoxetine (ATX) sometime in 2015 was obtained
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.relation.ispartofseries
Medicina (TFG)
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 Spain
dc.rights.uri
dc.subject
dc.title
Study of the use of medicines for the treatment of attention deficit and hyperactivity disorder in Catalonia
dc.type
info:eu-repo/semantics/bachelorThesis
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.coverage.geolocation
east=1.5208623999999418; north=41.5911589; name=Catalunya
Localització